🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Several experts stated the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Material Removal

Based on the social media company, the platform has removed problematic material and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing reviews and step-by-step guides for mixing or administering at residence.

Within minutes of joining one community, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, health issues or past usage.

Product Details and Costs

Inside these groups, posts show dark colored parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially significant health risks”.